Navigation Links
Watson Receives FDA Approval for Generic DuoNeb(R)
Date:1/3/2008

CORONA, Calif., Jan. 2 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it has received final approval from the United States (U.S.) Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution in the 0.5 mg/3 mg strength.

Watson's Ipratropium Bromide and Albuterol Sulfate product is the generic equivalent to Dey, L.P.'s DuoNeb(R), which is indicated for the treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) in patients requiring more than one bronchodilator. For the 12 months ending September 2007, DuoNeb(R) and its generic equivalents had total U.S. sales of approximately $265 million, according to IMS Health data. Watson intends to launch its Ipratropium Bromide and Albuterol Sulfate product immediately.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, CA, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watsonpharm.com.

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
10. DaVita Receives Civil Complaint
11. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... On Sunday, more than 900 runners and ... cross the finish line at the Rock ‘n’...m, raising over $3.2 million for the Crohn,s &...ning program, Team Challenge (www.ccteamchallenge)...ill go toward research, education, and support ini...
(Date:12/2/2009)...ATLANTA, Dec. 2 In response to ris...tary, FamilyLife, a non-profit ministry dedicated ... its Weekend to Remember® marriage conferen...n Atlanta from Dec. 11 - 13 at the Grand Hyatt Atl...nd to Remember is a marriage getaway aimed at str...
(Date:12/2/2009)... Ad in Today,s Washington Post Highlights Da...wire/ -- If the Catholic bishops have their way...s we take for granted may be under threat. The pr... the debate over healthcare reform has been widely...t warns of the likely impact if that pressure to ...
(Date:12/2/2009)... , KANSAS CITY, Mo., Dec. 2 ...h a comprehensive, practical view on proposed heal...,, (Logo: http://www.newscom.com/cgi-bin/prnh/...is good, bad, and ugly in the legislation, accordi...Lockton Benefit Group,s Compliance Services Divis...
(Date:12/2/2009)...yriad microbes in tobacco, but risk is unclear , ...New research provides evidence that the average ci... that cause respiratory disease. , But as one s...thors of the new study aren,t sure what, if any, h...nothing new: Microbes surround us every day of our...
Breaking Medicine News(10 mins):Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 2Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 3Health News:Raising Millions for Team Challenge through Rock ‘n' Roll Las Vegas Half Marathon Program Brings Hundreds From Across the Country to Raise Funds for Crohn's & Colitis 4Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2Health News:Smokers Inhaling Germs With Each Cigarette 2
...obesity stats, the American Heart Association (AHA...ucation programs// in the daily curriculum. ... of years, and in order for them to be as physical... nine practical steps to see that kids exercise mo...
...rchers says that getting married may benefit depre...rlier studies have documented marriage as being be...t this is the first study to look at the mental he...co-author Adrianne Frech, a doctoral student in so...
...as approved the new anti-smoking drug called Chant... on the body//. Research on the effects of this d...ers were able to completely quit smoking, which ha...fectively blocks the withdrawal symptoms. Manufact...
...t his life when some students pushed him from the .../ on the floor. Qamar Irfan, a Class 5 studen...Manihas village, died Thursday. Police said Q... the class as soon as school opened and sat on the...
...e plan for six new private finance initiative hosp... cutbacks// in their budgets. The announcement...nue the largest hospital building programme in the... Under the plans, , Bart’s and the London will lo...
...ch is needed to to fill in the gaps in HIV vaccine...itut Pasteur//, France, at the 16th International ...to Dr. Barré-Sinoussi there have been 85 HIV vacci...ussi said that recent advances in fundamental immu...
Other Medicine News:Health News:Proposal to Build Six new Hospitals Met with Rage 2
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNews...ncluding a late-breaking presentation on Tasigna&#...nic myeloid leukemia, demonstrate the strength of ...e care of patients. ,, The new data, at the 51...ting and Exposition, highlight the company,s curre...
(Date:12/1/2009)... , NEW YORK, Dec . 1 Re...h report is available in its catalogue: ,, Ins..., http://www.reportlinker.com/p0164247/Insulin-P...Insulin pumps, also called Continuous Subcutaneous...ver diabetes, when compared to other forms of trea...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Re...h report is available in its catalogue: ,, HPL...w ,, http://www.reportlinker.com/p0164366/HPL...l ,, Over the years, Liquid Chromatography has...s, pharmaceuticals, food and beverage, research an...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Carondelet St Marys Medical Plaza II Opens In Tucson 55314 1Long term tamoxifen use increases risk of an aggressive hard to treat type of second breast cancer 55312 1Long term tamoxifen use increases risk of an aggressive hard to treat type of second breast cancer 55312 2UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 1UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 2UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 3
Narkomed GS
...in facilities where space is a premium Fabius Tiro...technologies with an ergonomic and compact design....raeger Infinity patient monitoring range allows yo...is a sound investment into the future. The open mo...
...eveloped using Datex-Ohmedas unique approach to an...uous collaboration with clinicians. It combines th...atex-Ohmeda monitoring technology into an affordab...out the world, ,The contemporary, compact design ...
... Absorbent Wound Dressing is a sterile, single use... dressing applications. The synthetic matrix abso... wound contours, and entraps slough and necrotic d... The strands of the matrix are bound together by ...
Medicine Products: